These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 17907679)

  • 1. The Solid Mechanics of Cancer and Strategies for Improved Therapy.
    Stylianopoulos T
    J Biomech Eng; 2017 Feb; 139(2):. PubMed ID: 27760260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy.
    Basar OY; Mohammed S; Qoronfleh MW; Acar A
    Front Cell Dev Biol; 2024; 12():1369597. PubMed ID: 38813084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selected current data on metronomic therapy (and its promise) from India.
    Parikh PM; Hingmire SS; Deshmukh CD
    South Asian J Cancer; 2016; 5(2):37-47. PubMed ID: 27275444
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and Toxicity Assessment of Different Antibody Based Antiangiogenic Drugs by Computational Docking Method.
    Mukherjee S; Chatterjee G; Ghosh M; Das B; Majumder D
    Adv Bioinformatics; 2016; 2016():7053712. PubMed ID: 27047544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approach to modeling of antiangiogenic treatment on the basis of Hahnfeldt et al. model.
    Poleszczuk J; Bodnar M; Foryś U
    Math Biosci Eng; 2011 Apr; 8(2):591-603. PubMed ID: 21631148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal and suboptimal protocols for a mathematical model for tumor anti-angiogenesis in combination with chemotherapy.
    Ledzewicz U; Maurer H; Schättler H
    Math Biosci Eng; 2011 Apr; 8(2):307-23. PubMed ID: 21631132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy.
    Yonucu S; Yιlmaz D; Phipps C; Unlu MB; Kohandel M
    PLoS Comput Biol; 2017 Sep; 13(9):e1005724. PubMed ID: 28922358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robustness of optimal controls for a class of mathematical models for tumor anti-angiogenesis.
    Schättler H; Ledzewicz U; Cardwell B
    Math Biosci Eng; 2011 Apr; 8(2):355-69. PubMed ID: 21631134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical modelling for the assessment of the effect of drug application delays in metronomic chemotherapy of cancer due to physiological constraints.
    Mukherjee A; Majumder D
    Biosystems; 2008 Jan; 91(1):108-16. PubMed ID: 17889991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical modelling of toxicity-related trade-offs in metronomic chemotherapy.
    Majumder D; Mukherjee A
    IET Syst Biol; 2007 Sep; 1(5):298-305. PubMed ID: 17907679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to metronomic chemotherapy and ways to overcome it.
    Riesco-Martinez M; Parra K; Saluja R; Francia G; Emmenegger U
    Cancer Lett; 2017 Aug; 400():311-318. PubMed ID: 28259819
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.